During the past decade, Southeastern Medical Oncology Center-Goldsboro conducted 145 clinical trials. In the 10-year time frame, 145 clinical trials started and 86 clinical trials were completed, i.e. on average, 59.3% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 62 clinical trials were completed. i.e. 137.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southeastern Medical Oncology Center-Goldsboro" #1 sponsor was "National Cancer Institute (NCI)" with 87 trials, followed by "SWOG Cancer Research Network" with 37 trials sponsored, "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "Wake Forest University Health Sciences" with 13 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeastern Medical Oncology Center-Goldsboro" #1 collaborator was "National Cancer Institute (NCI)" with 102 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "AstraZeneca" with 3 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Southeastern Medical Oncology Center-Goldsboro" are "Breast Cancer" (11 trials), "Stage IV Breast Cancer AJCC v6 and v7" (9 trials), "HER2/Neu Negative" (8 trials), "Invasive Breast Carcinoma" (8 trials) and "Recurrent Breast Carcinoma" (8 trials). Many other conditions were trialed in "Southeastern Medical Oncology Center-Goldsboro" in a lesser frequency.

Most popular intervention types in "Southeastern Medical Oncology Center-Goldsboro" are "Drug" (181 trials), "Other" (120 trials), "Biological" (76 trials), "Procedure" (48 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (57 trials), "Quality-of-Life Assessment" (45 trials), "Computed Tomography" (31 trials), "Questionnaire Administration" (27 trials) and "Biospecimen Collection" (25 trials). Other intervention names were less common.

The vast majority of trials in "Southeastern Medical Oncology Center-Goldsboro" are 177 trials for "All" genders, 37 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Southeastern Medical Oncology Center-Goldsboro". undefined are not yet recruiting, 51 are recruiting, 86 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 68 completed trials in Southeastern Medical Oncology Center-Goldsboro, 3 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Southeastern Medical Oncology Center-Goldsboro, 8 "Phase 1" clinical trials were conducted, 103 "Phase 2" clinical trials and 117 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".

Southeastern Medical Oncology Center-Goldsboro has several departments that took part in Clinical trials: "Southeastern Medical Oncology Center-Jacksonville" - 167 trials, "Southeastern Medical Oncology Center-Clinton" - 164 trials